Addus HomeCare Corporation (ADUS)
$
110.91
-2.22 (-2.00%)
Key metrics
Financial statements
Free cash flow per share
4.8982
Market cap
2.1 Billion
Price to sales ratio
1.7033
Debt to equity
0.2520
Current ratio
1.7428
Income quality
1.2242
Average inventory
0
ROE
0.0824
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Addus HomeCare Corporation, along with its subsidiaries, delivers vital personal care services to elderly individuals, those with chronic illnesses, and disabled persons, as well as individuals at risk of hospitalization or institutionalization across the United States. The company operates through three primary segments: Personal Care, Hospice, and Home Health. The Personal Care segment is dedicated to providing non-medical support with daily activities, including bathing, grooming, oral care, feeding, dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. In the Hospice segment, Addus offers palliative nursing care, social work, spiritual counseling, homemaker assistance, and bereavement counseling for terminally ill patients and their families. Meanwhile, the Home Health segment caters to individuals requiring skilled nursing and therapies such as physical, occupational, and speech therapy during illness or post-hospitalization. The company's payor clients encompass federal, state, and local government agencies, managed care organizations, commercial insurers, and private individuals. As of December 31, 2021, Addus served consumers through 206 offices across 22 states. The gross profit stands at $375,021,000.00 highlighting the company's profitability from core operations. The company incurred an income tax expense of $25,755,000.00 indicating its tax obligations. The income before tax ratio is 0.09 reflecting the pre-tax margin. The company recorded a net income of $73,598,000.00 reflecting its profitability. Additionally, the weighted average number of shares outstanding is 17,006,000.00 highlighting the company's shareholder base. The stock is reasonably priced at $113.13 appealing to a broad range of investors. Despite having a low average trading volume of 213,090.00 indicating lower market activity, Addus HomeCare maintains a mid-range market capitalization of $2,040,644,181.00 positioning it as a steady performer. The company is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape. It belongs to the Healthcare sector, driving innovation and growth. This blend of stable operations and strategic market positioning makes Addus HomeCare a notable presence in its field, attracting interest from investors while fulfilling a crucial role in providing care to those in need.
Is Addus HomeCare Corporation (ADUS) a good investment?
Investing in Addus HomeCare Corporation (ADUS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bearish outlook. Always conduct your own research before investing.
What is Addus HomeCare Corporation (ADUS)'s stock forecast?
Analysts predict Addus HomeCare Corporation stock to fluctuate between $88.96 (low) and $136.72 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Addus HomeCare Corporation's market capitalization?
As of 2025-05-30, Addus HomeCare Corporation's market cap is $2,040,644,181, based on 18,399,100 outstanding shares.
How does Addus HomeCare Corporation compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Addus HomeCare Corporation has a Lower Market-Cap, indicating a difference in performance.
How can I buy Addus HomeCare Corporation (ADUS) stock?
To buy Addus HomeCare Corporation (ADUS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ADUS. Place an order (Market, Limit, etc.).
What is the best time to invest in Addus HomeCare Corporation?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did Addus HomeCare Corporation perform in the last earnings report?
Revenue: $1,154,599,000 | EPS: $4.33 | Growth: 12.47%.
Where can I find Addus HomeCare Corporation's investor relations reports?
Visit https://addus.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Addus HomeCare Corporation?
You can explore historical data from here
What is the all-time high and low for Addus HomeCare Corporation stock?
All-time high: $136.72 (2025-01-22) | All-time low: $68.57 (2022-02-24).
What are the key trends affecting Addus HomeCare Corporation stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
Addus HomeCare Corporation (NASDAQ:ADUS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Dru Anderson - Senior Partner-FINN Partners Dirk Allison - Chairman & Chief Executive Officer Brian Poff - Chief Financial Officer Brad Bickham - President & Chief Operating Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Joanna Gajuk - Bank of America Tao Qiu - Macquarie Jared Haase - William Blair Matthew Gillmor - KeyBanc Meghan Holtz - Jefferies Constantine Davides - Citizens Bank Ryan Langston - TD Cowen John Ransom - Raymond James Operator Good day, and welcome to the Addus HomeCare First Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode.
zacks.com
While the top- and bottom-line numbers for Addus HomeCare (ADUS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zacks.com
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks?
zacks.com
Addus HomeCare (ADUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.com
Addus HomeCare (ADUS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
zacks.com
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?
zacks.com
Addus HomeCare (ADUS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zacks.com
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks?
zacks.com
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
businesswire.com
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will participate in the following investor conferences: Oppenheimer 35th Annual Healthcare MedTech & Services Conference on Tuesday, March 18, 2025. Members of the management team will parti.
See all news
